Format

Send to

Choose Destination
Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S32-7.

Pharmacokinetics of Ginkgo biloba extracts.

Author information

1
Research and Development, Dr. Willmar Schwabe GmbH & Co. KG, 76227 Karlsruhe, Germany. anton.biber@schwabe.de

Abstract

EGb 761 (definition see editorial) Ginkgo extract is produced by a validated production process. Its pharmacologically active constituents, flavonol glycosides and terpene lactones, are kept within a narrow range of 22 to 27 % and 5 to 7 %, respectively, by standardisation. The concentration of ginkgolic acids is below 5 ppm. The constant production process also maintains the concentrations of other constituents such as proanthocyanidins, carboxylic acids and non-flavone glycosides at a fairly constant level. In this article, we will summarise the data on the pharmacokinetics of flavonol glycosides and terpene lactones.

PMID:
13130386
DOI:
10.1055/s-2003-40446
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center